"Founded in San Antonio, Texas as one of the few international laboratories with the ability to offer cancer cytogenetics, molecular genetics and multicolor flow cytometry services at one location, CorePath brings academic expertise, compassion and state of the art technology to help physicians help their patients and achieve the most accurate time-sensitive results for early treatment. Together, we are a highly-specialized team with a shared passion: “Caring for Lives.”"

During the past decade, CorePATH Laboratories conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CorePATH Laboratories" are "Chronic Lymphoproliferative Diseases (CLPD)" (2 trials), "Acute Leukemia" (1 trials) and "Plasma Cell Disorder" (1 trials). Many other conditions were trialed in "CorePATH Laboratories" in a lesser frequency.

Most popular intervention types in "CorePATH Laboratories" are "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "BD OneFlow LST, and B-CLPD T1 to T4 Assays" (1 trials), "IUO Acute Leukemia Panel" (1 trials), "IUO CLPD Limited Panel" (1 trials) and "IUO Plasma Cell Disorders Panel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CorePATH Laboratories" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CorePATH Laboratories". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CorePATH Laboratories, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CorePATH Laboratories, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".